🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Great presentation from Dana-Farber Lank Center for Genitourinary Oncology urologist, research fellow and superstar Clara Steiner working on KIM-1 with great mentorship from Wenxin (Vincent) Xu !

Tour de force presentation on HIF2A expression and clinical outcomes in ccRCC and sarc-Rcc by Dana-Farber Lank Center for Genitourinary Oncology superstar Rashad Nawfal, MD! Sylvan Baca MD PhD (Hiring!) Dana-Farber #FreedmanLab

Amazing work on merlin protein deficiency and bilallelic NF2 loss in RCC by our very own Dana-Farber Lank Center for Genitourinary Oncology star Emre Yekedüz ! Dana-Farber Yüksel Ürün OncoAlert

Awesome presentation from IM Huntsman Cancer Institute PGY-1 and star Georges Gebrael! Another testament to Neeraj Agarwal, MD, FASCO superb mentorship.

Fantastic presentation by Dana-Farber Lank Center for Genitourinary Oncology superstar Eddy Saad about TLS detection in mRCC! Dana-Farber Eli Van Allen

Spectacular presentation from Dana-Farber Lank Center for Genitourinary Oncology superstar/computational biologist Karl Semaan, MD, MSc. First work to show longitudinal monitoring of NEPC using liquid biopsy! With super mentorship from Sylvan Baca MD PhD (Hiring!) #FreedmanLab

Excellent presentation from the #IMDC superstar lead fellow Razane El Hajj Chehade #RHC assessing low vs low-intermediate substrata of IMDC risk groups! Daniel Heng Sylvan Baca MD PhD (Hiring!) Dana-Farber

Great presentation by Dana-Farber Lank Center for Genitourinary Oncology superstar fellow Marc Machaalani, MD investigating KIM-1 as a circulating biomarker in mRCC! Dana-Farber Wenxin (Vincent) Xu

Outstanding presentation by our phenomenal epigenetics star Marc Eid discussing liquid biopsy epigenomic profiling of sarc #RCC! #FreedmanLab Sylvan Baca MD PhD (Hiring!) Dana-Farber Lank Center for Genitourinary Oncology OncLive.com

Sky is the limit with our phenomenal Karl Semaan, MD, MSc discussing plasma cfChIP in detecting and monitoring NE transformation in #prostatecancer! Excited to see where this outstanding physician-scientist will match! ASCO #GU25 Sylvan Baca MD PhD (Hiring!) #FreedmanLab Razane El Hajj Chehade Marc Eid

Fighting through sleep deprivation and the fire hydrant of GU onc knowledge, beginning with OncLive.com Fellows Forum on Wednesday to last through this final day of ASCO #GU25 with the Cleveland, Salt Lake City and Boston team! Until #GU26... No ☕ for me 😁

⭐️Future of GU oncology is VERY bright. LOVED learning about the cutting edge research of the Fellows and trainees at OncLive.com GU Fellows forum at #GU25. Also really enjoyed joining global GU leaders and superb mentors Dr. Choueiri Dr. McKay and Dr. Garcia as they provided

Proud of you Eddy Saad ! Thank you BIDMC IM Residency ! Dana-Farber Lank Center for Genitourinary Oncology Dana-Farber Eli Van Allen

Proud of you Karl Semaan, MD, MSc ! We are Sylvan Baca MD PhD (Hiring!) #FreedmanLab proud! Thank you Brigham and Women's Medicine Residents ! Dana-Farber Lank Center for Genitourinary Oncology Dana-Farber

Incredibly honored and thrilled to have matched at my top choice BIDMC IM Residency! Beyond grateful to my amazing mentors, friends, and family who supported me every step of the way Toni Choueiri, MD Eli Van Allen David Braun Sasha Gusev Maxine Sun

I am absolutely thrilled to have matched at Brigham and Women's Medicine Residents Brigham and Women's Hospital for internal medicine residency! Incredibly grateful to my amazing mentors, colleagues, and friends who have supported me throughout this journey Sylvan Baca MD PhD (Hiring!) #MattFreedman Toni Choueiri, MD #Match2025

At #AACR25, Dana-Farber researchers present a non-invasive method to distinguish classical vs. basal #PDAC using circulating tumor epigenomic profiles which could pave the way for more personalized treatment decisions. #PancreaticCancer #CancerResearch Karl Semaan, MD, MSc Marc Eid

Fantastic presentation by Renee Maria Saliby discussing our work evaluating MAdCAM-1, a circulating surrogate of gut dysbiosis, as a biomarker in patients with mRCC! #ASCO25 ASCO Toni Choueiri, MD Carolina Alves Costa Silva, MD, PhD OncoAlert

.Toni Choueiri, MD takes the stage to present data from the phase 1 ARC-20 trial that shows that the combination of HIF2 inhibitor casdatifan plus cabo has promising clinical activity (cORR 46%) and an acceptable safety profile in pretreated pts w/ mRCC. #ASCO25 ASCO OncoAlert

Looking at HIF signaling outside of RCC? These guys did it! Wassim Daoud Khatoun and #Jad! Check out their poster at 📍458 OncoAlert #ASCO25